Published in Surgery Litigation and Law Weekly, January 7th, 2005
The study is a single arm pilot study in 30 patients. The primary endpoint of the trial will be complete response measured by complete clearance of baseline internal warts. The study is on schedule and 12-month data are estimated to be available at the end of 2005.
Stephen E. Goldstone, MD, a Fellow of the American College of Surgeons and clinical assistant professor at The Mount...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly